Your browser doesn't support javascript.
loading
Pasireotide for the treatment of refractory hypoglycaemia from malignant insulinoma.
Hendren, Nicholas S; Panach, Kamaldeep; Brown, Timothy J; Peng, Lan; Beg, Muhammad S; Weissler, Jonathan; Mirfakhraee, Sasan.
  • Hendren NS; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Panach K; Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Brown TJ; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Peng L; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Beg MS; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Weissler J; Division of Pulmonology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Mirfakhraee S; Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Clin Endocrinol (Oxf) ; 88(2): 341-343, 2018 02.
Article en En | MEDLINE | ID: mdl-29055143

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Somatostatina / Hipoglucemia / Insulinoma Límite: Female / Humans / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Somatostatina / Hipoglucemia / Insulinoma Límite: Female / Humans / Middle aged Idioma: En Año: 2018 Tipo del documento: Article